Clover Health Investments, Corp. Announces Proposed Public Offering of Class A Common Stock
2021年11月16日 - 6:19AM
Clover Health Investments, Corp. (Nasdaq: CLOV), (“Clover Health”),
a technology company committed to improving health equity for
seniors, today announced that it has commenced an underwritten
public offering of 35,000,000 shares of its Class A Common Stock.
All of the shares are being offered by Clover Health. In
conjunction with the offering, Clover Health intends to grant to
the underwriters a 30-day option to purchase up to 5,250,000
additional shares of its Class A Common Stock. The offering is
subject to market and other conditions, and there can be no
assurance as to whether or when the offering may be completed, or
as to the actual size or terms of the offering.
Clover Health intends to use the net proceeds from this offering
for working capital and general corporate purposes.
Citigroup and Deutsche Bank Securities are acting as joint
book-running managers for the offering. SVB Leerink and Canaccord
Genuity LLC are acting as book-runners for the proposed
offering.
The offering will be made only by means of a prospectus. Copies
of the preliminary prospectus relating to the proposed offering may
be obtained, when available, by contacting: Citigroup Global
Markets Inc., c/o Broadridge Financial Solutions, 1155 Long Island
Avenue, Edgewood, NY 11717, telephone: 1-800-831-9146 or email:
prospectus@citi.com; or Deutsche Bank Securities Inc., Attn:
Prospectus Department, 1 Columbus Circle, New York, New York 10019,
telephone: 800-503-4611 or email: prospectus.cpdg@db.com Before
investing in this offering, interested parties should read in its
entirety the preliminary prospectus, which provides more
information about Clover Health and the offering.
No Offer or Solicitation
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities in any jurisdiction
to any person to whom it is unlawful to make an offer, solicitation
or sale in such jurisdiction. A registration statement relating to
these securities has been filed with the SEC but has not yet become
effective. These securities may not be sold nor may offers to buy
be accepted prior to the time the registration statement becomes
effective.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. Forward-looking statements include statements regarding
the offer and sale of shares, the terms of the offering and
expected use of proceeds to be received by it in the offering.
These statements are subject to known and unknown risks,
uncertainties and other factors that may cause our actual results
to differ materially from results expressed or implied in this
press release, including but not limited to the risks and
uncertainties contained in the Risk Factors section of our
Quarterly Report on Form 10-Q for the quarter ended September 30,
2021, which we filed with the Securities and Exchange Commission on
November 9, 2021, the preliminary prospectus supplement related to
the proposed public offering and subsequent filings with the SEC.
Clover Health assumes no obligation, and does not intend, to update
these forward-looking statements as a result of future events or
developments.
Contact Information
Investor Relations:Derrick Nuemaninvestors@cloverhealth.com
Press Contact:Andrew Still-Baxterpress@cloverhealth.com
Clover Health Investments (NASDAQ:CLOVW)
過去 株価チャート
から 8 2024 まで 9 2024
Clover Health Investments (NASDAQ:CLOVW)
過去 株価チャート
から 9 2023 まで 9 2024